The kinase Mirk is a potential therapeutic target in osteosarcoma-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

The kinase Mirk is a potential therapeutic target in osteosarcoma

Published:2009-12-30 Issue:4 Volume:31 Page:552-558
ISSN:0143-3334
Container-title:Carcinogenesis
language:en
Short-container-title:Carcinogenesis

Author:

Yang C.,Ji D.,Weinstein E. J.,Choy E.,Hornicek F. J.,Wood K. B.,Liu X.,Mankin H.,Duan Z.

Publisher

Oxford University Press (OUP)

Subject

Cancer Research,General Medicine

Link

http://academic.oup.com/carcin/article-pdf/31/4/552/7518229/bgp330.pdf

Reference34 articles.

1. Biology and Therapeutic Advances for Pediatric Osteosarcoma

2. Poor prognosis osteosarcoma: new therapeutic approach

3. Treatment Recommendations for Osteosarcoma and Adult Soft Tissue Sarcomas

4. Multiple Drug Resistance in Osteogenic Sarcoma: INT0133 From the Children's Oncology Group

5. Osteosarcoma Relapse After Combined Modality Therapy: An Analysis of Unselected Patients in the Cooperative Osteosarcoma Study Group (COSS)

Cited by 41 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Hepatic Dyrk1b impairs systemic glucose homeostasis by modulating Wbp2 expression in a kinase activity-dependent manner;Heliyon;2024-09

2. Mirk/Dyrk1B Kinase Inhibitors in Targeted Cancer Therapy;Pharmaceutics;2024-04-11

3. CMGC Kinases in Health and Cancer;Cancers;2023-07-28

4. Genomic and proteomic profiling of osteosarcoma;Bone Cancer;2022

5. Recent research and development of DYRK1A inhibitors;Chinese Chemical Letters;2021-10

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3